FoxO3a (Forkhead Box O3a) Deficiency Protects Idiopathic Pulmonary Fibrosis (IPF) Fibroblasts from Type I Polymerized Collagen Matrix-Induced Apoptosis via Caveolin-1 (cav-1) and Fas

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Nho, Richard Seonghun ^a   Peterson, Mark ^a   Hergert, Polla ^a   Henke, Craig A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CASPASE 3; CASPASE 7; CAVEOLIN 1; COLLAGEN TYPE 1; FAS ANTIGEN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHRL1;

APOPTOSIS; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; FIBROSING ALVEOLITIS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG FIBROBLAST; PROMOTER REGION; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; UPREGULATION;

ANTIGENS, CD95; APOPTOSIS; CASPASE 3; CAVEOLIN 1; CELL LINE; COLLAGEN TYPE I; FIBROBLASTS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; PHENOTYPE; PROTEIN MULTIMERIZATION; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE;

EID: 84875985279     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061017     Document Type: Article

References (54)

1. Gharaee-Kermani M, Gyetko MR, Hu B, Phan SH, (2007) New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy. Pharm Res 24: 819-41.
2. Kuhn C, McDonald JA, (1991) The roles of the myofibroblast in idiopathic pulmonary fibrosis. Am J Pathol 138: 1257-1265.
3. Ryu JH, Colby TV, Hartman TE, (1998) Idiopathic pulmonary fibrosis: current concepts. Mayo Clin Proc 73: 1085-101.
4. Ask K, Martin GE, Kolb M, Gauldie J, (2006) Targeting genes for treatment in idiopathic pulmonary fibrosis: challenges and opportunities, promises and pitfalls. Proc Am Thorac Soc 3: 389-93.
5. Horowitz JC, Thannickal VJ, (2006) Idiopathic pulmonary fibrosis: new concepts in pathogenesis and implications for drug therapy. Treat Respir Med 5: 325-42.
6. Wight TN, Potter-Perigo S, (2011) The extracellular matrix: an active or passive player in fibrosis? Am J Physiol Gastrointest Liver Physiol 301: G950-5.
7. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, et al. (1999) Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol 277: C1-9.
8. Yamashita M, Yamauchi K, Chiba R, Iwama N, Date F, et al. (2009) The definition of fibrogenic processes in fibroblastic foci of idiopathic pulmonary fibrosis based on morphometric quantification of extracellular matrices. Hum Pathol 40: 1278-87.
9. Nho RS, Xia H, Diebold D, Kahm J, Kleidon J, et al. (2006) PTEN regulates fibroblast elimination during collagen matrix contraction. J Biol Chem 281: 33291-301.
10. Xia H, Diebold D, Nho R, Perlman D, Kleidon J, et al. (2008) Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmonary fibrosis. J Exp Med 205: 1659-72.
11. Nho RS, Hergert P, Kahm J, Jessurun J, Henke C, (2011) Pathological alteration of FoxO3a activity promotes idiopathic pulmonary fibrosis fibroblast proliferation on type I collagen matrix. Am J Pathol 179: 2420-30.
12. Xia H, Khalil W, Kahm J, Jessurun J, Kleidon J, et al. (2010) Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis. Am J Pathol 176: 2626-37.
13. Nho RS, Kahm J, (2010) beta1-Integrin-collagen interaction suppresses FoxO3a by the coordination of Akt and PP2A. J Biol Chem 285: 14195-209.
14. Kato M, Yuan H, Xu ZG, Lanting L, Li SL, et al. (2006) Role of the Akt/FoxO3a pathway in TGF-beta1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease. J Am Soc Nephrol 17: 3325-35.
15. Lin H, Dai T, Xiong H, Zhao X, Chen X, et al. (2010) Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. PLoS One 5: e15797.
16. Naka K, Hoshii T, Muraguchi T, Tadokoro Y, Ooshio T, et al. (2010) TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature 4 463: 676-80.
17. Shukla S, Shukla M, Maclennan GT, Fu P, Gupta S, (2009) Deregulation of FOXO3A during prostate cancer progression. Int J Oncol. 34: 1613-20.
18. Nakae J, Barr V, Accili D, (2000) Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR. EMBO J 19: 989-96.
19. Nakao T, Geddis AE, Fox NE, Kaushansky K, (2008) PI3K/Akt/FOXO3a pathway contributes to thrombopoietin-induced proliferation of primary megakaryocytes in vitro and in vivo via modulation of p27(Kip1). Cell Cycle 7: 257-66.
20. Yusuf L, Zhu X, Kharas MG, Chen J, Fruman DA, (2004) Optimal B-cell proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors. Blood 104: 784-787.
21. Behzad H, Jamil S, Denny TA, Duronio V, (2007) Cytokine-mediated FOXO3a phosphorylation suppresses FasL expression in hemopoietic cell lines: investigations of the role of Fas in apoptosis due to cytokine starvation. Cytokine 38: 74-83.
22. Cornforth AN, Davis JS, Khanifar E, Nastiuk KL, Krolewski JJ, (2008) FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells. Oncogene 27: 4422-33.
23. Dabrowska A, Kim N, Aldovini A, (2008) Tat-induced FOXO3a is a key mediator of apoptosis in HIV-1-infected human CD4+ T lymphocytes. J. Immunol. 181: 8460-77.
24. Huang H, Tindall DJ, (2006) FOXO factors: a matter of life and death. Future Oncol 2: 83-9.
25. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, et al. (1992) Caveolin, a protein component of caveolae membrane coats. Cell 68: 673-82.
26. Wang XM, Zhang Y, Kim HP, Zhou Z, Feghali-Bostwick CA, et al. (2006) Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med 203: 2895-906.
27. Sotgia F, Williams TM, Schubert W, Medina F, Minetti C, et al. (2006) Caveolin-1 deficiency (-/-) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness. Am J Pathol 168: 292-309.
28. Thomas S, Overdevest JB, Nitz MD, Williams PD, Owens CR, et al. (2011) Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer. Cancer Res 71: 832-41.
29. Williams TM, Lisanti MP, (2005) Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 288: C494-506.
30. van den Heuvel AP, Schulze A, Burgering BM, (2005) Direct control of caveolin-1 expression by FOXO transcription factors. Biochem J 385(Pt 3): 795-802.
31. Furuyama T, Nakazawa T, Nakano I, Mori N, (2000) Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem J 349: 629-34.
32. Tsai KL, Sun YJ, Huang CY, Yang JY, Hung MC, et al. (2007) Crystal structure of the human FoxO3a-DBD/DNA complex suggests the effects of post-translational modification. Nuc Acids Res 35: 6894-6994.
33. Cichy SB, Uddin S, Danilkovich A, Guo S, Klippel A, et al. (1998) Protein kinase B/Akt mediates effects of insulin on hepatic insulin-like growth factor-binding protein-1 gene expression through a conserved insulin response sequence. J Biol Chem 273: 6482-7.
34. Capozza F, Williams TM, Schubert W, McClain S, Bouzahzah B, et al. (2003) Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation. Am J Pathol 162: 2029-39.
35. Zhang M, Lin L, Lee SJ, Mo L, Cao J, et al. (2009) Deletion of caveolin-1 protects hyperoxia-induced apoptosis via survivin-mediated pathways. Am J Physiol Lung Cell Mol Physiol 297: L945-53.
36. Zhang M, Lee SJ, An C, Xu JF, Joshi B, et al. (2011) Caveolin-1 mediates Fas-BID signaling in hyperoxia-induced apoptosis. Free Radic Biol Med 50: 1252-62.
37. Wynes MW, Edelman BL, Kostyk AG, Edwards MG, Coldren C, et al. (2011) Increased cell surface Fas expression is necessary and sufficient to sensitize lung fibroblasts to Fas ligation-induced apoptosis: implications for fibroblast accumulation in idiopathic pulmonary fibrosis. J Immunol 187: 527-37.
38. de Souza PM, Lindsay MA, (2005) Apoptosis as a therapeutic target for the treatment of lung disease. Curr Opin Pharmacol 5: 232-7.
39. Zheng WH, Kar S, Quirion R, (2000) Insulin-like growth factor-1-induced phosphorylation of the forkhead family transcription factor FKHRL1 is mediated by Akt kinase in PC12 cells. J Biol Chem 275: 39152-8.
40. Kulasekaran P, Scavone CA, Rogers DS, Arenberg DA, Thannickal VJ, et al. (2009) Endothelin-1 and transforming growth factor-beta 1 independently induce fibroblast resistance to apoptosis via Akt activation. Am J Respir Cell Mol Biol 41: 484-93.
41. Horowitz JC, Rogers DS, Sharma V, Vittal R, White ES, et al. (2007) Combinatorial activation of FAK and AKT by transforming growth factor-beta 1 confers an anoikis-resistant phenotype to myofibroblasts. Cell Signal 19: 761-71.
42. Brunet AB, Bonni A, Zigmond MJ, Lin MZ, Juo P, et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96: 857-868.
43. Greer EL, Brunet A, (2005) FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24: 7410-25.
44. Ho WC, Pikor L, Gao Y, Elliott BE, Greer PA, (2012) Calpain 2 regulates Akt-FoxO-p27(Kip1) protein signaling pathway in mammary carcinoma. J Biol Chem 287: 15458-65.
45. Abid MR, Schoots IG, Spokes KC, Wu SQ, Mawhinney C, et al. (2004) Vascular endothelial growth factor-mediated induction of manganese superoxide dismutase occurs through redox-dependent regulation of forkhead and IkappaB/NF-kappaB. J Biol Chem 279: 44030-8.
46. Dong XC, Copps KD, Guo S, Li Y, Kollipara R, et al. (2008) Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metab 8: 65-76.
47. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G, (2006) Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 174: 810-6.
48. Flachsbart F, Caliebe A, Kleindorp R, Blanché H, von Eller-Eberstein H, et al. (2009) Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc Natl Acad Sci 106: 2700-5.
49. Liu JW, Chandra D, Rudd MD, Butler AP, Pallotta V, et al. (2005) Induction of prosurvival molecules by apoptotic stimuli: involvement of FOXO3a and ROS. Oncogene 24: 2020-31.
50. Demou ZN, Awad M, McKee T, Perentes JY, Wang X, et al. (2005) Lack of telopeptides in fibrillar collagen I promotes the invasion of a metastatic breast tumor cell line. Cancer Res 65: 5674-82.
51. Christiansen DL, Huang EK, Silver FH, (2000) Assembly of type I collagen: fusion of fibril subunits and the influence of fibril diameter on mechanical properties. Matrix Biol 19(5): 409-20.
52. Sato K, Ebihara T, Adachi E, Kawashima S, Hattori S, et al. (2000) Possible involvement of aminotelopeptide in self-assembly and thermal stability of collagen I as revealed by its removal with proteases. J Biol Chem 275: 25870-5.
53. Kuznetsova N, Leikin S, (1999) Does the triple helical domain of type I collagen encode molecular recognition and fiber assembly while telopeptides serve as catalytic domains? Effect of proteolytic cleavage on fibrillogenesis and on collagen-collagen interaction in fibers. J Biol Chem 274: 36083-8.
54. Li GN, Livi LL, Gourd CM, Deweerd ES, Hoffman-Kim D, (2007) Genomic and morphological changes of neuroblastoma cells in response to three-dimensional matrices. Tissue Eng 13: 1035-47.